Thomas W. Beetham - Chief Operating Officer at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
VRDN on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

Thomas W. Beetham - trading volume in the past year for Viridian Therapeutics, Inc.\DE

Holdings reported by Thomas W. Beetham for Viridian Therapeutics, Inc.\DE

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 37.6K $881K $23.41 Mar 3, 2025 Direct Common Stock
Common Stock 6K $140K $23.41 Sep 27, 2024 Direct
Stock Option (Right to Buy) 226K Mar 3, 2025 Direct Common Stock

Transactions reported by Thomas W. Beetham for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.